← Back to Search

Behavioral Intervention

Mindful Self-Compassion for Lung Cancer (MSC-LC) for Lung Cancer

N/A
Recruiting
Led By Timothy J Williamson, Ph.D., MPH
Research Sponsored by Loyola Marymount University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Is at least 18 years of age as per self report
Has a confirmed lung cancer diagnosis, as per self-report and confirmed by clinician judgment or medical record note
Timeline
Screening 3 weeks
Treatment Varies
Follow Up study entry, 5 weeks (mid-intervention), 10 weeks (post-intervention), 16 weeks (long-term follow-up)
Awards & highlights

Study Summary

This trial is testing a mindfulness-based program called Mindful Self-Compassion for Lung Cancer (MSC-LC) in adults with lung cancer who experience stigma. The goal is to see if this

Who is the study for?
This trial is for adults with lung cancer who feel stigmatized because of their diagnosis. Participants will be randomly assigned to either learn mindfulness and self-compassion skills in a virtual group setting over 10 weeks or placed on a waitlist while receiving standard mental health resources.Check my eligibility
What is being tested?
Researchers are testing a new program called Mindful Self-Compassion for Lung Cancer (MSC-LC) against an enhanced standard of care. They want to see if MSC-LC can help reduce feelings of stigma and increase self-kindness among lung cancer patients.See study design
What are the potential side effects?
Since this intervention involves mindfulness and self-compassion exercises, it's not expected to have physical side effects. However, discussing sensitive topics like stigma may cause temporary emotional discomfort.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I have been diagnosed with lung cancer, confirmed by my doctor.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~study entry, 5 weeks (mid-intervention), 10 weeks (post-intervention), 16 weeks (long-term follow-up)
This trial's timeline: 3 weeks for screening, Varies for treatment, and study entry, 5 weeks (mid-intervention), 10 weeks (post-intervention), 16 weeks (long-term follow-up) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Lung Cancer Stigma Inventory
Secondary outcome measures
Functional Assessment of Chronic Illness Therapy - Spiritual Well-Being, meaning and peace subscales
Generalized Anxiety Disorder-7
Patient Health Questionnaire-8
+1 more
Other outcome measures
Number of intervention sessions that each consented participant attended
Treatment fidelity

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Mindful Self-Compassion for Lung Cancer (MSC-LC)Experimental Treatment1 Intervention
Group-based psychosocial intervention adapted from Mindful Self-Compassion that focuses on the development of mindfulness and self-compassion skills to reduce lung cancer stigma.
Group II: Enhanced standard of care with waitlistActive Control1 Intervention
Control group that will receive a list of mental health resources and will complete questionnaire assessments during a parallel timeframe as participants in the intervention condition and be placed on a waiting list to receive the MSC-LC intervention after study completion.

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,728 Previous Clinical Trials
40,965,933 Total Patients Enrolled
Loyola Marymount UniversityLead Sponsor
5 Previous Clinical Trials
6,005 Total Patients Enrolled
Timothy J Williamson, Ph.D., MPHPrincipal InvestigatorLoyola Marymount University
~40 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top